Proportion of isolates with resistance to ciprofloxacin reported to in United States of America
United States of America: Proportion of isolates with resistance to ciprofloxacin reported to was 31.22 in 2018. ▲ Rising
Proportion of isolates with resistance to ciprofloxacin reported to in United States of America, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
United States of America recorded 31.22 for proportion of isolates with resistance to ciprofloxacin reported to in 2018. That is the highest value across all 10 years on record.
Compared with earlier readings it is up 3.7% on the previous year and up 224.3% over ten years.
Over the whole period, proportion of isolates with resistance to ciprofloxacin reported to in United States of America peaked at 31.22 in 2018 and was at its lowest, 9.63, in 2009.
That places United States of America 50th out of 54 countries with data for 2018, putting it in the bottom quarter.
Proportion of isolates with resistance to ciprofloxacin reported to in United States of America, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 9.63 | — |
| 2010 | 12.45 | +29.4% |
| 2011 | 13.28 | +6.6% |
| 2012 | 14.72 | +10.9% |
| 2013 | 16.06 | +9.1% |
| 2014 | 19.2 | +19.5% |
| 2015 | 22.32 | +16.3% |
| 2016 | 26.81 | +20.1% |
| 2017 | 30.11 | +12.3% |
| 2018 | 31.22 | +3.7% |
United States of America compared with similar countries
- United States of America's 31.22 is below the median for high income countries, which is 55.25, 57% of the median. (34 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9.63 | 9.63 | 9.63 | 1 |
| 2010s | 20.69 | 12.45 | 31.22 | 9 |
Countries ranked near United States of America
More health data for United States of America
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,069 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,015 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2023)
- Population ages 00-04, female, annual growth rate 0.056 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0261 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.1919 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with resistance to ciprofloxacin reported to in United States of America?
- Proportion of isolates with resistance to ciprofloxacin reported to in United States of America was 31.22 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to ciprofloxacin reported to recorded in United States of America?
- The highest recorded value was 31.22 in 2018.
- What is the lowest proportion of isolates with resistance to ciprofloxacin reported to recorded in United States of America?
- The lowest recorded value was 9.63 in 2009.
- How does United States of America rank for proportion of isolates with resistance to ciprofloxacin reported to?
- United States of America ranks 50th out of 54 countries with data for 2018.
- Is proportion of isolates with resistance to ciprofloxacin reported to rising or falling in United States of America?
- Over the last ten years it is up 224.3%. The long-run trend across the full record is rising.
- Where does this United States of America data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).